Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics (NYSE: DGX) declared a quarterly cash dividend of $0.66 per share, scheduled for payment on July 20, 2022. Shareholders of record as of July 6, 2022 will receive this dividend. This distribution reflects the company’s commitment to returning value to its investors.
Quest Diagnostics is a leader in diagnostic services, serving one in three adult Americans and half of U.S. physicians and hospitals. Its insights aim to improve health outcomes and healthcare management.
- Quarterly cash dividend of $0.66 per share announced.
- Dividend to be paid on July 20, 2022, demonstrating commitment to shareholder value.
- Strong position as a leading provider of diagnostic information services.
- None.
SECAUCUS, N.J., May 17, 2022 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-301549615.html
SOURCE Quest Diagnostics
FAQ
What is the dividend amount declared by Quest Diagnostics?
When will the dividend be paid to shareholders?
Who are eligible shareholders for the Quest Diagnostics dividend?
